Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

Under the terms of the agreement, Acorda will receive an up-front payment of $2.5 million, a near term milestone payment of up to $6 million, $3 million up...

May 09, 2023 | Tuesday | News
China Approves KN026 + Chemotherapy Phase III Study for Breast Cancer Treatment

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. jointly announced that the IND application was approved in China for t...

May 09, 2023 | Tuesday | News
New Developments Show Ophthalmology Embracing Myopia Control & Management

Two newly published pieces indicate that the ophthalmology community is more broadly embracing myopia control and management, according to global cat...

May 09, 2023 | Tuesday | News
BeiGene Receives New Approvals for BRUKINSA® (zanubrutinib) in China

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the China National Medical Products Administration (NMPA)...

May 08, 2023 | Monday | News
Junshi Biosciences and Dr. Reddy's Partner to Develop Toripalimab in 21 Countries.

“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...

May 08, 2023 | Monday | News
SomaLogic Launches Proteomics Grant Program for APAC Researchers

SomaLogic, Inc., a global leader in proteomics technology, announced that it is sponsoring the Genomax Research Grant Award for researchers in Singapore. T...

May 08, 2023 | Monday | News
Bolivian & Taiwanese Experts Discuss Med-Tech to Position Bolivia as Robotic Neurosurgery Leader

"The Future of Robotic Surgery," over 400 medical specialists gathered to participate in a dynamic exchange of ideas and insights. The ...

May 04, 2023 | Thursday | News
China Phase II Clinical Study of Osemitamab Completes Enrollment for First-Line Gastric Cancer Treatment

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

May 03, 2023 | Wednesday | News
EirGenix's EG1206A Meets Phase 1 Trial Objectives as Breast Cancer Biosimilar

EG1206A is a biosimilar drug of the second-generation HER2-positive antibody drug Perjeta® (pertuzumab). EG1206A has a unique binding mechanism for HER...

May 03, 2023 | Wednesday | News
Eppendorf and Clustermarket Partner for Seamless Integration of Lab Management Tools

With research and development being a time-consuming industry, there is a constant need for time-saving digital solutions and tools. Nowadays, most laborat...

May 03, 2023 | Wednesday | News
Ascletis' Once-Daily Oral FASN Inhibitor, ASC40, Meets Phase II Endpoint for Acne

ASC40 is an oral, selective small molecule inhibitor of FASN. Mechanisms of ASC40 for acne are (1) direct inhibition of facial sebum production, through in...

May 03, 2023 | Wednesday | News
Merck to Establish BioProcessing Production Center in South Korea

MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daejeon City...

May 03, 2023 | Wednesday | News
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health

PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Austr...

May 02, 2023 | Tuesday | News
The Clinician to participate at Digital Health Festival 2023 in Melbourne

As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...

May 01, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close